Search Results

Get your space suits on, GPCR cadets! up with a series of cosmic GPCR events for the year ahead. muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development Classified GPCR News  Let’s dive into the   Classified GPCR News from October 28th to November 3rd, 2024 muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development

Even the most elegant GPCR ligand can fail if it never reaches its receptor. resistance, tune selectivity, and design molecules that adapt to real cellular environments—not just ideal assay Bring your toughest pharmacology questions — from receptor bias and assay design to enzyme kinetics — Kenakin with your own enzyme or GPCR interaction puzzles. Direct input  on future sessions—so topics match the hurdles your team faces in discovery and development

Terry’s Corner: Schild Analysis — Why It Matters Most assays show a clean rightward shift and we assume Who should listen Researchers navigating complex datasets, balancing innovation with assay rigor, or GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record, GPCR Team

You can have the most brilliant minds and cutting-edge assays, but if your science isn't continuously My work isn't just  about the latest and best assay; it's about the framework that ensures the right assay data leads to the right decision. GPCR, we recognized this core problem. We'll look at how overlooked operational details, such as misaligned data from diverse GPCR assay types

Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target early — when it matters most. ✅ Practical ways  to integrate kinetics, allostery, and bias into smarter development The real friction point lies downstream : translating receptor–ligand interactions into actionable development How CRO Communication Impacts GPCR Drug Development Success Even the best science falters without operational Direct input  on future sessions—so topics match the hurdles your team faces in discovery and development

New scaffolds modulating the CBRs in both the orthosteric and allosteric sites have been developed, supported It has been applied to different GPCR binding assays, such as CXCR4, opioid receptors, CCK1 and CCK2. Results 2.1  CELT-335 Binding at CB1 and CB2 Receptors The first step for the development of the assay Using these results as a starting point, the Tag-lite® binding assay was developed. and the Tag-lite® binding assay developed in this work. ( a ) CB1R binding affinities; ( b ) CB2R binding

Welcome GPCR Fans,   Every discovery-phase decision you make shapes your entire pipeline trajectory—and Upcoming events:  5th MMCS New Trends in Drug Discovery; GPCR-UK Network Meeting; neuroGPCR Symposium Must-read publications:  GPCRchimeraDB: Database of engineered GPCR designs. GPCR University Course Attendee Dr. The pace of GPCR innovation is accelerating.

Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing to replace inference with models that disentangle mechanism—so your next go/no-go, dose range, and assay Engineer assays on purpose:  Set ranges, controls, and system sensitivity to surface mechanism—before Assay flexibility:  Combine self-labeling tags with quantitative readouts (e.g., TR-FRET) to expand mechanism GPCR innovation is accelerating.

We've got 11 GPCR papers, seven industry news pieces, a new GPCR event, and even a job ad.   new cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target coverage codon-optimized clytin II gene in Chinese hamster ovary-K1 cells and its use in the G-protein-coupled receptor assays Events, Meetings, and Webinars September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays GPCR Ecosystem

The dysfunction of these receptors has been linked to the development of many serious pathologies, like Thus, developing assays for commercially available probes such as CELT-419 would facilitate research Probe characterization and assay development and validation 3.1  Characterization of CELT-419 in radioligand To validate that the developed assay is suitable for measuring the K i of different ligands, competition Altogether, the development of similar probes for other GPCRs and further development of measurement

visibility and adoption of Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive GPCR assays. About Celtarys Research Celtarys Research is a biotech company based in Spain that specializes in the development assay development, screening, and live-cell imaging.

GPCR. Dear Dr. a place for teams to get tailored scientific and strategic guidance that helps bridge discovery and development Our access program for researchers in developing countries  continues as well: eligible scientists can GPCR University course reserves five complimentary seats for students from developing countries — no GPCR About Dr. GPCR Dr.

GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. GPCR Premium Membership Gives You an Edge In a world filled with noise, Dr. GPCR Premium Membership delivers curated, noise-free intelligence every week. The pace of GPCR innovation is accelerating. , Yamina's Corner, biotech, systems thinking, signal transduction, operational excellence, drug development

August 2022 "G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that serve Classically, GPCR internalization has been considered to lead to receptor desensitization. Here, this review summarizes different PTMs in GPCR internalization and analyzes their significance in , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews

partnership built on trust and curiosity — reshaped both careers and helped unlock a new generation of GPCR How a Collaboration Led to a GPCR Imaging Breakthrough JB didn’t set out to contribute to a GPCR imaging It was the start of a scientific partnership with the potential to shift how GPCRs could be visualized Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges. Many of the connections that shaped the probes’ development came from simple conversations that began

Every computational hypothesis moves downstream into experimental assays via close collaborations. GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural Why Predictive GPCR Modeling Matters Now The convergence of machine learning, improved GPCR structures , and scalable experimental assays is shrinking the gap between modeling and pharmacology. Want to go deeper into GPCR modeling? Dr.

Exploring the Hidden Dynamics: How Kinetics Reveals What Equilibrium Conceals in GPCR Research. Hi GPCR Community, If equilibrium curves are your comfort zone, this week’s feature will challenge (and right way, detect time-dependent occupancy and complex activity, leverage hemi-equilibrium calcium assays GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record,

GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

A single successful GPCR imaging experiment can transform a project’s trajectory. Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. And the most striking validation came from in vivo GPCR imaging. Strong GPCR imaging tools come from strong interdisciplinary relationships.  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

This Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week because the assay was flawed—but because in vivo counterregulation  neutralized the response. GPCR Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists GPCR innovation is accelerating. GPCR and the offered resources in my work sphere." — DrGPCR University Attendee GPCR innovation doesn

Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. This solved a long-standing problem in GPCR biology: You can't understand signaling if you can’t see  Collaboration, Chemistry, and the Pivot That Changed the Project Goal:  Develop a photo-switchable GPCR The Larger Lesson for Scientists and Innovators This story isn’t just about a GPCR imaging tool.

proteins that participate in many vital physiological functions making them a popular target for drug development for the role of oligomerization in receptor signaling came from ensemble biochemical and biophysical assays Here, we review recent developments in single-molecule counting with a focus on photobleaching step counting Read more at the source #DrGPCR #GPCR #IndustryNews

For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating understanding allosteric modulation have opened up new avenues for drug development. GPCR activity, enabling greater specificity and fewer side effects. mechanisms Allosteric sites can differentially modulate G-protein and β-arrestin coupling, enabling the development allosteric agonists and establish a strong foundation for developing biased drugs targeting GPCRs.

explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." GPCRs in the Background, But Always Present Even though his primary focus wasn’t GPCRs themselves, Serafini Serafini highlighted that in modern pain drug development, the field has remained too focused on ion Takeaway Forget what you think you know about GPCR drug targets.

Industry insights:  New alliances, pipeline shifts, and platform tech that could reshape metabolic drug development Localization Matters : Protein complexes pre-assemble at membranes, altering how ligands trigger responses. • Assay Development Gets Real : Fluorescent tools and real-world biology don’t always match. University access are coming—grandfather pricing ends in 2026. • Inclusive Growth : More access for developing Whether you’re designing the next assay, scouting a new therapeutic angle, or exploring career pivots

In GPCR drug discovery, a single mistaken assumption can derail an entire program. pharmacologists misinterpret how an antagonist interacts with its receptor, the consequences ripple across assay development, SAR interpretation, and clinical translation. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate

Following the Data Into GPCR, Metabolic Disease and GLP-1 After his PhD, Hodson entered neuroendocrinology GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Can GPCRs act as “delivery ZIP codes” for targeted therapies?

the cell ✅ Tools for evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface In a traditional assay, they look the same. But in vivo? The good news: we now have reliable, low-cost assays to find out —Kenakin walks through the essential GPCRs now have validated intracellular  allosteric sites.

GPCR research requires turning data into insights for drug discovery Hi GPCR Friends, Every week, critical validate differences, confirm subtle shifts, and benchmark your results against literature or across assay Validate with confidence:  Benchmark your results against literature standards and confirm whether your assays GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr. The pace of GPCR innovation is accelerating.

These limitations can impact data quality, reproducibility, and assay flexibility. How Fluorescent Ligands Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional tag is a key part of the flow cytometry assay, as there are several key factors to be considered: 1. Tag brightness and stability:  the brighter and more stable the better the assay outcome. 2.       Illuminating the life of GPCRs.